Minerva Surgical, Inc. (UTRS)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 29, 2026

Minerva Surgical Company Description

Minerva Surgical, Inc. provides a suite of devices to treat the root causes of abnormal uterine bleeding in the United States.

The company provides Minerva Endometrial Ablation System, a technology that uses three methods of tissue ablation; Symphion System that is designed for fluid management, direct intrauterine pressure monitoring, and bladeless resection work; and Genesys HTA, an endometrial ablation device for the treatment of a wider range of uterine cavities.

It also offers Resectr, a tissue resection device to diagnose and treat polyps; and HERizon electronic disposable hysteroscope, image processor, Hysto-Kit, and endoscopic accessories that helps gynecologists to evaluate abnormal uterine bleeding and provide care.

The company was incorporated in 2008 and is headquartered in Santa Clara, California.

Minerva Surgical, Inc.
Country United States
Founded 2008
Industry Medical Devices
Sector Healthcare
Employees 174
CEO Darin Hammers

Contact Details

Address:
4255 Burton Drive
Santa Clara, California 95054
United States
Phone 855 646 7874
Website minervasurgical.com

Stock Details

Ticker Symbol UTRS
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number US60343F1066
SIC Code 3841

Key Executives

Name Position
Darin Hammers Chief Executive Officer
Greg Simbro Vice President of Finance
Wendy Bowman Vice President of Human Resources
Dr. Evgueni V. Skalnyi M.D. Chief Medical Officer
Brent Palmisano Chief Commercial Officer
Joanne Long Vice President of Corporate Controller